UNSPSC 51171637: Lactitol

This classification denotes an artificial sweetener with the molecular formula C12H24O11, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L2B0WJF7ZY, chemically known as d-glucitol, 4-o-beta-d-galactopyranosyl- but generally known as lactitol, which bears US NIH Compound Identifier 91476. European Medicines Agency schedules Lactitol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08385MIG.

UNSPSC 51171637 Lactitol, a Commodity code, nominally addresses a specific pharmaceutical ingredient but receives little directly aligned activity in recent state and local procurement. The three most recent opportunities tagged to this code involve drug-testing services, direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals distribution through cooperative purchasing—none of which center on lactitol as a procured input. State and local governments appear to use this code infrequently or to classify pharmacy-related solicitations more broadly rather than to source lactitol specifically. The issuing bodies span county criminal-justice departments (Collin County Community Supervision and Corrections Department), state health authorities (Texas Health and Human Services Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance). When activity does appear, it reflects purchasing at the program level—specimen collection and drug testing, prescription fulfillment models, and bulk pharmaceutical distribution—rather than procurement of ingredient-level commodities like lactitol.

Recent opportunities with this code show minimal geographic concentration. The Collin County offender drug-testing RFP (posted July 9, 2026, due July 23, 2026, estimated value $600,000) is Texas-based; the Texas HHS Commission's Therapeutic Pharmacy Initiative RFI (issued April 3, 2026) is statewide; and the Minnesota Multistate Cooperative Purchasing Alliance's generic pharmaceuticals RFP (posted January 20, 2026, due March 26, 2026) spans Minnesota and Oregon participating jurisdictions. None of these opportunities explicitly solicit lactitol. The mismatch between the code's nominal scope and the actual procurement activity suggests that this code either sees minimal real-world use in state and local procurement or that jurisdictions frequently misapply it to pharmacy-related work that does not involve lactitol procurement. Business development professionals evaluating this code should treat recent activity as a weak signal and verify sourcing opportunities through direct vendor and procurement-office outreach rather than relying on UNSPSC classification.